Difference between revisions of "Cancer United"
Bob Burton (talk | contribs) (SW: expand text to justify fronts tag) |
Bob Burton (talk | contribs) m (SW: add links) |
||
Line 20: | Line 20: | ||
===Sources=== | ===Sources=== | ||
<references/> | <references/> | ||
+ | |||
+ | ===Related SourceWatch Articles=== | ||
+ | *[[Drug industry]] | ||
===External Links=== | ===External Links=== |
Revision as of 02:49, 17 March 2008
This article is part of the Center for Media & Democracy's spotlight on front groups and corporate spin. |
Cancer United is a drug company front group established by Weber Shandwick and funded entirely by Roche.
In August 2006, Guardian journalist Sarah Boseley wrote ahead of the group's launch that it "is being presented as a pioneering effort by a coalition of doctors, nurses and patients to push for equal access to cancer care across the EU. However, the campaign is being entirely funded by Roche, the maker of Herceptin and Avastin. A senior company executive sits on the board. The company's PR firm Weber Shandwick is the secretariat and has been heavily promoting it to clinicians and journalists. And the principal study on which it is based has been hotly contested - and was also funded by Roche."[1]
Contents
Contact Details
Web: http://www.cancerunited.org/
SourceWatch Resources
- Health Care
- Midwest Heart Foundation
- Doctor Run Charities
- Patient Groups/Australia
- Patient Groups/Europe
- Patient Groups/International
- Patient Groups/UK
- Patient Groups/US
- Patient Groups/Canada
Articles and Resources
Sources
- ↑ Sarah Boseley, "Concern over cancer group's link to drug firm", Guardian (UK), October 18, 2006.
Related SourceWatch Articles
External Links
- Sarah Boseley, "Concern over cancer group's link to drug firm", Guardian (UK), October 18, 2006.
- Faisal Islam , "Roche faces cancer probe", Channel Four, October 19, 2006.
- Sarah Boseley and David Gow, "Support for cancer group naive, says MP", Guardian (UK), October 20, 2006.
- Sarah Boseley, "Hiding behind the patients: Of course drug companies have a voice in the debate about cancer care. But they should be more open about it", Comment IS Free (Guardian blog), October 20, 2006.
- David Miller 'This campaign brought to you by...' Spinwatch, 29 October 2006.